Yinghao Wang (Wang Yinghao)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Signaling Pathway

Cardiovascular Disease

Top Venues

Pharmaceuticals (Basel, Switzerland)

Journal of diabetes research

This page only lists publications with an associated author ORCID identifier.

Publications

Yinghao Wang, Guanfu Liu, Xutao Liu, Minhua Chen, Yuping Zeng, Yuyan Li, Xiaoyun Wu, Xuanjun Wang, Jun Sheng
Serpentine Enhances Insulin Regulation of Blood Glucose through Insulin Receptor Signaling Pathway. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Yinghao Wang, Guanfu Liu, Xutao Liu, Minhua Chen, Yuping Zeng, Yuyan Li, Xiaoyun Wu, Xuanjun Wang, Jun Sheng
Serpentine Enhances Insulin Regulation of Blood Glucose through Insulin Receptor Signaling Pathway. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Yinghao Wang, Guanfu Liu, Xutao Liu, Minhua Chen, Yuping Zeng, Yuyan Li, Xiaoyun Wu, Xuanjun Wang, Jun Sheng
Serpentine Enhances Insulin Regulation of Blood Glucose through Insulin Receptor Signaling Pathway. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Yinghao Wang, Guan Qiaoli, Guanfu Liu, Xiaoyun Wu, Wang Xuanjun, Sheng Jun
2'-O-Methylperlatolic Acid Enhances Insulin-Regulated Blood Glucose-Lowering Effect through Insulin Receptor Signaling Pathway. Journal of diabetes research 2022 (2022)